DMRA
Damora Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $240.1M | 14.35% | +2.07% | |
| 2 | Fairmount Funds ManagementFairmount Funds | $226.6M | 13.54% | 0.00% | |
| 3 | venBio Select AdvisorvenBio Select Advisor | $98.4M | 5.88% | 0.00% | |
| 4 | VR AdviserVR Adviser | $93.7M | 5.60% | 0.00% | |
| 5 | BlackRockBlackRockindex-like | $82.2M | 4.91% | +1321.56% | |
| 6 | Fcpm III Services B.V.Fcpm III Services B.V. | $63.5M | 3.79% | 0.00% | |
| 7 | RA Capital ManagementRA Capital Management | $62.4M | 3.73% | +0.02% | |
| 8 | Viking Global InvestorsViking Global Investors | $60.1M | 3.59% | 0.00% | |
| 9 | Jupiter TopcoJupiter Topco | $59.3M | 3.54% | — | |
| 10 | Remedium Capital PartnersRemedium Capital Partners | $53.2M | 3.18% | 0.00% | |
| 11 | Commodore CapitalCommodore Capital | $50.4M | 3.01% | 0.00% | |
| 12 | JPMorgan ChaseJPMorgan Chase | $49.8M | 2.98% | new | |
| 13 | BraidwellBraidwell | $42.1M | 2.52% | +81.08% | |
| 14 | Bellevue GroupBellevue | $42.1M | 2.52% | −29.55% | |
| 15 | State StreetState Streetindex-like | $40.2M | 2.40% | +740.30% | |
| 16 | AH Capital ManagementAH Capital Management | $32.2M | 1.92% | 0.00% | |
| 17 | Balyasny Asset ManagementBalyasny | $32.0M | 1.91% | −15.12% | |
| 18 | Perceptive AdvisorsPerceptive | $31.8M | 1.90% | 0.00% | |
| 19 | Wellington Management GroupWellington | $27.5M | 1.64% | 0.00% | |
| 20 | Blackstone GroupBlackstone | $26.1M | 1.56% | +99.19% | |
| 21 | Cormorant Asset ManagementCormorant | $26.0M | 1.55% | −34.43% | |
| 22 | Geode Capital ManagementGeodeindex-like | $25.1M | 1.50% | +300.36% | |
| 23 | SirenSiren | $23.4M | 1.40% | 0.00% | |
| 24 | UBS GroupUBS | $21.9M | 1.31% | +423.82% | |
| 25 | Vestal Point CapitalVestal Point Capital | $15.0M | 0.89% | −4.17% |
Fund move
No thesis.
104 managers report $1.7B of Damora Therapeutics on form 13F for the quarter ended Jun 30 '26. 18 of them hold 80% of it; FMR is largest at 14.35%.
Damora Therapeutics, Inc.
21.50
−0.51 · −2.30%
post 21.50 0.00%
Largest filed tie
—
No implied move.
No implied move.
Expected move
No implied move.